Articles on
Bulls came under immediate pressure on Monday, and the late afternoon was all about the retreat. The Nasdaq 100 closed at 11,912, a loss of 2.1%, states Jon Markman, editor of Strategic Advantage.
Jon Markman
MARKETS
The January advance continued. Nine of eleven S&P SPDR sectors were higher, notes Bonnie Gortler of bonniegortler.com.
Bonnie Gortler
ETFs
Andrew Aziz, the founder of Bear Bull Traders, isn't afraid to go deep. As he openly shares with host Kim Ann Curtin in this episode of The Wall Street Coach Podcast, "nine months ago, I was worth $3 million more on paper."
Kim Ann Curtin
TOOLS
We’re at a fascinating juncture here in the markets. Stocks have sold off hard for a little over a year now but have rallied once again in the short run, exclaims Jesse Felder of TheFelderReport.com.
Jesse Felder
MARKETS
Tickers: SPX
Airlines have been the butt of investing jokes for years, and the pandemic was another reason to doubt the group as many posted giant losses, asserts Mike Cintolo, editor of Cabot Top Ten Trader.
Michael Cintolo
TRANSPORTATION
Tickers: UAL
Energy stock Marathon Petroleum Corp. (MPC) was just recently trading at a new all-time high, observes Jake Scott, technical expert and deputy editor at Schaeffer Investment Research.
Jake Scott
ENERGY
Tickers: MPC
Most economic indicators are bearish in early 2023: manufacturing and corporate profits are declining and technology companies are laying off workers, observes Mark Skousen, editor of Forecasts & Strategies.
Mark Skousen
FINANCIALS
Tickers: MAIN
The Carlyle Group (CG) — a private equity giant — hit a rough patch the past year, with a pullback of over 38% as high interest rates and weak global equity markets resulted in a slowdown in dealmaking, recalls notes Todd Shaver, editor of Bull Market Report.
Todd Shaver
FINANCIALS
Tickers: CG
The flow of earnings will pick up noticeably from today onwards and reach a crescendo next week as we move into February, writes Ian Murphy of MurphyTrading.com.
Ian Murphy
ECONOMY
Tickers: SPX
Do you have dreams and goals that you want to accomplish? We all do, but it’s easy for our best-laid plans to go awry when life throws us curveballs, says Steve Burns of New Trader U.
Steve Burns
TOOLS
Zaheer Anwari
TRADING
$139.00
2:01:36
New
Virtual Learning
If you are 50+ years of age, you don't have time for wild movements in the stock market that could delay or destroy your retirement. No one wants to run out of money, and we all want to live the lifestyle we envision. But, the old buy-and-hope strategy, which holds a basket of assets during market corrections, is risky and inefficient at best. Imagine if you could sell your investments as they started to top. Then, revest the money into different assets rising in value, and never have to hold falling positions again. By owning only assets rising in value, you can avoid multi-year drawdowns, reduce financial stress, and achieve an uncompromised retirement. Introducing CGS, Consistent Growth Strategy, where some see random price movements, we see investing signals--everywhere. Signals from stocks, bonds, commodities, and currencies that we convert into actionable investing signals.
Chris Vermeulen
TOOLS
33:20
Gideon Pfeffer offers a fantastic opportunity to invest with a best-class operator in a brand new, Class A apartment community in the 2nd most competitive apartment market in the United States. The investment boasts strong cash flow from day one, tax benefits from accelerated depreciation, and a 20% discount on the originally marketed sales price. This presentation will surely satisfy all your passive investing requirements.
Gideon Pfeffer
REAL ESTATE
31:43
Big money can be made after markets fall if you know when and where to buy. Come to this research-driven presentation, filled with data from dozens of credible sources, to learn what to expect with housing prices in 2023 and 2024 (note, it's not good news). As always, bad news means opportunity for investors who have been sitting on the sidelines. Let's find out what those opportunities are, and how you can benefit from them. At the end of this presentation, you'll know exactly what economic indicators trigger a buying opportunity in real estate.
Neal Bawa
REAL ESTATE
30:48
Private mortgage investments offer some of the most favorable risk-adjusted returns available on the market, and in a high-interest environment, they can provide 15-18% ROI per year. Because mortgages are well collateralized, there is a near zero risk of borrower default; thus providing the most sustainable and worry-free passive income for savvy investors.
Laura Scarlett Martin
REAL ESTATE
32:38
Kyle Hyden, managing director of equity sales at NOYACK Capital, will share the benefits of investing in supply chain real estate. NOYACK Logistics Income REIT operates with a high conviction (supported by a data-driven investment thesis) that logistics assets are undervalued relative to the market maturity of eCommerce. Learn about the demand drivers and how your portfolio may benefit from secular growth tailwinds, durable income distributions, and enhanced diversification. Join to learn how NOYACK Capital strategically invests in America's supply chain infrastructure underpinning the economy's growing digitalization.
Kyle Hyden
REAL ESTATE
26:56
Join us for a short briefing and booth tour of Hornet, Noyack Capital, Akru, and The GSH Group.
Mike Larson
STRATEGIES
6:31
Join Ryan Wilday as he continues to discuss how important $16K is for Bitcoin. It is the line between a new bullish cycle and a more extended bear move. Ryan will take a look at recent action and discuss whether that level can hold, and what to expect if it doesn't.
Ryan Wilday
Cryptocurrency
17:22
Hemali Dassani
ALTERNATIVE INVESTMENTS
27:46
John McCamant has spent 35 years on the front lines of biotech investing as an equities analyst and in venture capital. He has also edited the Medical Technology Stock Letter since the year 2000. In this session, he'll tell you about the methodology he uses to sift through hundreds of biotech companies to find the best in class drugs like MDGL for long-term growth. Plus, John will highlight the most attractive biotech opportunities in this premier growth sector for the rest of 2023 and beyond.
John McCamant
BIOTECH
28:05
